Cross-industry partnership reduces the cost of popular diabetes, asthma and other brand name drugs
Inside Rx, a new initiative from Express Scripts, partners with GoodRx, drug manufacturers and drug stores to save Americans an average of 34% at 40,000 pharmacies
Express Scripts has launched Inside Rx, a new, partially owned subsidiary that applies Express Scripts' purchasing power to expand affordable access to brand and generic medications for patients in need. Inside Rx has partnered with GoodRx, America's leading source for prescription drug prices and savings, to deliver average savings of 34% on prescription medications for the uninsured and those who experience high out-of-pocket costs for their prescription medications.
Patients can visit www.goodrx.com/brand or download the GoodRx mobile app to instantly access significant savings for more than 40 popular brand name drugs that treat diabetes, asthma, heart disease, depression, gastrointestinal disorders, gout, and other common illnesses. While savings vary per drug and pharmacy, eligible patients can save an average of 34% off of the drug's typical cash price, which could translate into savings of hundreds or even thousands of dollars per person per year.
Benefiting from these discounts is easy; eligible patients simply present the discount via card or mobile app at one of 40,000 pharmacies nationwide, including CVS, the Kroger Family of Pharmacies and Walgreens. There are no membership fees or costs to obtain savings. A complete list of available medications and participating pharmacies are available at www.insiderx.com.
"We have a unique opportunity to put medicine within reach of those who need it. By practicing pharmacy smarter, we are bringing together companies across healthcare to truly deliver value," said Express Scripts President and CEO Tim Wentworth. "We are proud to power a novel solution that makes brand-name medicines more affordable and accessible, particularly for people without prescription coverage."
The program represents an important, and unique, cross-industry collaboration among Inside Rx, GoodRx, participating retail pharmacies, and major pharmaceutical companies, including Boehringer Ingelheim, Eli Lilly and Company, Lundbeck, Novo Nordisk, Sanofi, Takeda Pharmaceuticals and Teva Pharmaceuticals. All stakeholders share a focus to ensure patients have expanded access to affordable medications. Today, more than 30 million Americans pay the full cost of their prescriptions.
"The GoodRx / Inside Rx program is a simple and effective way to help millions of Americans who struggle to afford their prescriptions," said Doug Hirsch, co-founder and co-CEO of GoodRx. "GoodRx is proud to partner with Inside Rx to reduce the cost of diabetes, asthma and other important drugs that patients need."
"We are pleased to participate in Express Scripts' new program that will play an important role in helping under-insured and uninsured patients receive the medicines they need at a price they can afford," said Brad Fluegel, Senior Vice President, Chief Healthcare Commercial Market Development Officer, Walgreens.
"Kroger is excited to partner with Express Scripts on this new program that creates affordability and expands access to medications for many of our patients," said Colleen Lindholz, President of Pharmacy and The Little Clinic, The Kroger Co. Soon, Inside Rx cards also will be available at the Kroger Family of Pharmacy locations.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance